Sweden · Delayed Price · Currency is SEK Bufab AB Earnings Call Transcripts
Fiscal Year 2026
-
Organic growth and record-high margins were achieved despite cautious demand, with strong performance across most regions and improved cash flow. The balance sheet strengthened, and the company remains focused on margin improvement and market share gains.
Fiscal Year 2025
-
Delivered record gross and operating margins for the year, with modest growth despite weak markets. Major acquisitions and new contracts in key industries set the stage for continued margin improvement and market share gains in 2026.
-
Organic growth returned at 1.4% with record gross and operating margins, driven by market share gains and new contracts. The Novia Group acquisition and a major defense sector agreement strengthen future prospects, though market uncertainty and temporary tariff effects remain.
-
Gross margin reached a record 31.1% and operating margin improved despite a 4.8% revenue decline, driven by cost reductions and efficiency gains. Segment performance was mixed, with Asia Pacific and Americas showing relative strength, while U.K. & Ireland lagged.
-
Sales returned to growth with a 1.6% increase, driven by strong Asia-Pacific performance and improved gross margin. Operating margin and cost control initiatives supported profitability, while US tariffs and market uncertainty remain key risks.
Fiscal Year 2024
-
Acquisition of Vital strengthened Southern Europe presence, while divestments refocused the business on trading and niche segments. Despite weak demand, gross margin reached a record 29.7% and organic growth improved sequentially, with further gradual improvement expected.
-
Organic growth improved to -2.6% with a record gross margin of 30.6% and strong cash flow, despite a 9.2% sales decline year-over-year. Segment performance varied, with Asia Pacific showing strong growth and Americas facing continued weakness. Market uncertainty persists, but margin and cash flow improvements position the group for future acquisitions.
-
Q2 net sales declined 6% year-over-year, but gross margin hit a record 29.8% and cash flow remained strong. Divestment of Lann & Hallborn completed, with continued focus on cost savings, margin improvement, and market share growth amid challenging market conditions.